simendan has been researched along with Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dosta-Herrera, JJ; Gutiérrez-Riveroll, KI; Mejía Picazo, HJ | 1 |
| Hummel, J; Rücker, G; Stiller, B | 1 |
| Burkhardt, BE; Rücker, G; Stiller, B | 1 |
| Bertram, H; Görler, H; Happel, CM; Hitz, MP; Köditz, H; Wessel, A; Yelbuz, TM | 1 |
| Colucci, WS; Maytin, M | 1 |
| Gheorghiade, M; Mebazaa, A; Teerlink, JR | 1 |
| Barraud, D; Mebazaa, A; Welschbillig, S | 1 |
| Cardoso, JS; Follath, F; Franco, F | 1 |
| Adamopoulos, S; Farmakis, D; Filippatos, G; Kremastinos, D; Paraskevaidis, I; Parissis, JT | 1 |
| Antoniou, T; Degiannis, D; Geroulanos, S; Kriaras, I; Papadopoulos, K; Stavridis, G; Tasouli, A | 1 |
| Böhm, M; De Luca, L; Dickstein, K; El-Banayosy, A; Filippatos, G; Gheorghiade, M; Mebazaa, A; Nieminen, M; Parissis, JT; Rhodes, A; Voors, AA; Zannad, F | 1 |
| Andrade, AC; Mebazaa, A; Tavares, M | 1 |
9 review(s) available for simendan and Syndrome
| Article | Year |
|---|---|
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Topics: Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Heart Defects, Congenital; Humans; Hydrazones; Infant; Intensive Care Units, Pediatric; Length of Stay; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Respiration, Artificial; Simendan; Syndrome | 2017 |
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Heart Defects, Congenital; Humans; Hydrazones; Infant; Infant, Newborn; Milrinone; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome; Time Factors | 2015 |
Cardioprotection: a new paradigm in the management of acute heart failure syndromes.
Topics: Acute Disease; Animals; Cardiotonic Agents; Cells, Cultured; Heart Failure; Humans; Hydrazones; Hydrogen Peroxide; Myocytes, Cardiac; Oxidative Stress; Pyridazines; Rats; Simendan; Syndrome | 2005 |
Pharmacology of new agents for acute heart failure syndromes.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Pyridazines; Pyridines; Simendan; Syndrome; Tetrazoles; Tolvaptan; Vasodilator Agents | 2005 |
Randomized clinical trials with levosimendan.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome | 2005 |
European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Topics: Acute Disease; Cardiotonic Agents; Europe; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome | 2005 |
Levosimendan for the treatment of acute heart failure syndromes.
Topics: Acute Disease; Animals; Heart Failure; Humans; Hydrazones; Pyridazines; Radiography; Simendan; Syndrome | 2005 |
Overview of emerging pharmacologic agents for acute heart failure syndromes.
Topics: Adenosine; Cardiovascular Agents; Endothelin-1; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Hydrazones; Natriuretic Peptide, Brain; Perhexiline; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Sodium-Potassium-Exchanging ATPase; Syndrome; Vasodilator Agents | 2008 |
Levosimendan use in several scenarios of acute heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Contraindications; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypotension; Ischemia; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Syndrome; Vasodilator Agents | 2008 |
2 trial(s) available for simendan and Syndrome
| Article | Year |
|---|---|
[Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot].
Topics: Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hydrazones; Longitudinal Studies; Milrinone; Prospective Studies; Pyridazines; Simendan; Syndrome; Tetralogy of Fallot | 2022 |
Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hydrazones; Intraoperative Complications; Male; Middle Aged; Pyridazines; Simendan; Syndrome; Treatment Outcome | 2007 |
1 other study(ies) available for simendan and Syndrome
| Article | Year |
|---|---|
Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation.
Topics: Abnormalities, Multiple; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Cycle Proteins; Heart-Lung Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Proteins; Pyridazines; Simendan; Syndrome; Treatment Outcome; Waiting Lists | 2008 |